IFN-β MSCs produce a direct anti-proliferative and metastatic effects on tumor cells by suppressing the cell proliferation gene expression and time-dependent mesenchymal–epithelial transition (MET) inhibition, respectively (Du et al., 2019; Heo et al., 2019). The gene discussed is IFNB1; the disease is neoplasm.